Helsana Group (Switzerland)
- Research works
- 74 ▼ 7% vs 2013–17
- Citations
- 1.5k 20.8 per fractional work
- Top-10% rate
- 19.3% record average 16.5%
- Open access
- 75% world 28%
Not ranked overall: Helsana Group (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 12.5×
- Immunology and Microbiology 7.7×
- Medicine 2.9×
- Psychology 2.7×
- Health Professions 2.5×
- Economics, Econometrics and Finance 2.1×
- Decision Sciences 2.0×
- Business, Management and Accounting 0.8×
- Nursing 0.4×
- Social Sciences 0.4×
- Biochemistry, Genetics and Molecular Biology 0.3×
- Neuroscience 0.3×
- Earth and Planetary Sciences 0.2×
- Environmental Science 0.2×
Who are the top researchers at Helsana Group (Switzerland)?
Ranked on the composite score, Eva Blozik lead among researchers whose main affiliation is Helsana Group (Switzerland).
- 1 Eva Blozik Switzerland · #247,742 worldwide 259 citations · 16 works
Which keywords describe research at Helsana Group (Switzerland)?
By fractional works in all years, weighted toward what it does more of than the world: Primary Care, Epidemiology, Quality of Life, Healthcare Utilization, Public Health, Clinical Practice Guidelines, Health Outcomes and Chronic Disease Management.
- Infectious Diseases
- Polypharmacy
- Inappropriate Medication Use
- Ethical Considerations
- Health Surveys
- Clinical Trials
- Glycemic Control
- Treatment Adherence
- Patient Compliance
- Interventions
- Chronic Disease
- Depression
- Multimorbidity
- Informed Consent
- Quality Improvement
- Health Services
- Cardiovascular Disease
- Clinical Practice Guidelines
- Healthcare Utilization
- Primary Care
- Epidemiology
- Quality of Life
- Public Health
- Health Outcomes
- Chronic Disease Management
- Medication Adherence
- Comorbidity
- Chronic Conditions
- Cardiovascular Disease Prevention
- Genetic Testing
- Guidelines
- Medical Ethics
- Patient Rights
- Epidemiological Study
- Chronic Diseases
- Germany
- Diabetes
- Health System Reform
- Life Expectancy
- Economic Evaluation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology11▲ 3.7×29 topics
- Primary Care8▲ 27×9 topics
- Quality of Life6▲ 6.1×10 topics
- Healthcare Utilization5▲ 97×2 topics
- Public Health5▲ 5.2×6 topics
- Clinical Practice Guidelines4▲ 10×7 topics
- Health Outcomes4▲ 24×4 topics
- Cardiovascular Disease4▲ 4.7×12 topics
- Chronic Disease Management4▲ 35×3 topics
- Health Services4▲ 68×2 topics
- Medication Adherence3▲ 76×2 topics
- Quality Improvement3▲ 22×5 topics
- Comorbidity3▲ 44×2 topics
- Informed Consent3▲ 49×2 topics
- Chronic Conditions3▲ 81×1 topic
- Multimorbidity3▲ 139×1 topic
- Cardiovascular Disease Prevention3▲ 46×2 topics
- Depression3▲ 4.9×9 topics
- Genetic Testing3▲ 22×2 topics
- Chronic Disease2▲ 21×3 topics
- Guidelines2▲ 7.2×6 topics
- Interventions2▲ 39×2 topics
- Medical Ethics2▲ 20×1 topic
- Patient Compliance2▲ 164×1 topic
- Patient Rights2▲ 35×1 topic
- Treatment Adherence2▲ 164×1 topic
- Epidemiological Study2▲ 42×2 topics
- Glycemic Control2▲ 23×3 topics
- Chronic Diseases2▲ 11×2 topics
- Clinical Trials2▲ 4.8×9 topics
- Germany2▲ 98×1 topic
- Health Surveys2▲ 98×1 topic
- Diabetes2▲ 5.7×3 topics
- Ethical Considerations2▲ 7.8×2 topics
- Health System Reform2▲ 35×2 topics
- Inappropriate Medication Use2▲ 66×1 topic
- Life Expectancy2▲ 44×2 topics
- Polypharmacy2▲ 66×1 topic
- Economic Evaluation2▲ 18×2 topics
- Infectious Diseases2▲ 9.7×2 topics
Which research topics does Helsana Group (Switzerland) publish most on?
By volume in 2022–2025: Antibiotic Use and Resistance, Medication Adherence and Compliance, Chronic Disease Management Strategies and Antibiotics Pharmacokinetics and Efficacy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 1 works
- 2 Medication Adherence and Compliance Family Practice 0 works
- 3 Chronic Disease Management Strategies Epidemiology 0 works
- 4 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
- 5 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 6 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 7 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
- 8 COVID-19 and healthcare impacts Oncology 0 works
- 9 Pneumonia and Respiratory Infections Epidemiology 0 works
- 10 Treatment of Major Depression Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Helsana Group (Switzerland)'s research output changed?
Output in 2018–2022 was 7% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dübendorf
- Swiss Federal Laboratories for Materials Science and Technology
- Swiss Federal Institute of Aquatic Science and Technology
- Flisom (Switzerland)
- Micos Engineering (Switzerland)
- Kantonsarchäologie des Kantons Zürich
- Lib4RI - Library for the Research Institutes within the ETH Domain: Eawag, Empa, PSI & WSL
- envibee (Switzerland)
- Stanley Black & Decker (Switzerland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.